Lars Rejnmark

40PUBLICATIONS
137CO-AUTHORS
Clinical pharmacy and pharmacy practiceCardiology (incl. cardiovascular diseases)Photonics, optoelectronics and optical communicationsToxicology (incl. clinical toxicology)Pacific Peoples and disability
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Jul 13, 2026
Pharmacodynamics of sustained levels of PTH following palopegteriparatide treatment in adults with hypoparathyroidism.

|Jun 23, 2026
Increased Prevalence of Coronary Artery Calcification in Patients with Post-Surgical Hypoparathyroidism.

|May 12, 2026
Intratrabecular bone remodeling - a previously overlooked mode of remodeling hyperactivated by parathyroid hormone.

|Feb 04, 2026
Palopegteriparatide for adults with chronic hypoparathyroidism: skeletal dynamics through 3 years of the phase 2 PaTH forward trial.

Mishaela R Rubin, Bart L Clarke, Lorenz C Hofbauer

|Feb 19, 2025
Pain, Quality of Life, and Mental Health in Adults with X-linked Hypophosphatemia: A Cross-sectional Study.

Marta Diaz-delCastillo, Rasmus Bundgaard Espersen, Signe Sparre Beck-Nielsen

|Jan 15, 2025
Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia.

Dieter Haffner, Francesco Emma, Lothar Seefried

Pageof 7

Frequent Collaborators

8 joint publications

Aliya Khan

7 joint publications

John P Bilezikian

7 joint publications

Lars Rolighed

6 joint publications

Tanja Sikjaer